Search

Search Constraints

You searched for: Author/Creator Gottfried, Maya

Search Results

3. Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literature. (March 2017)

4. Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. (5th December 2013)

5. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%. Issue 21 (20th July 2021)

6. Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib. (5th July 2016)

7. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019)

8. Health-related quality of life in patients treated with pembrolizumab for microsatellite instability–high/mismatch repair–deficient advanced solid tumours: Results from the KEYNOTE-158 study. (July 2022)

9. Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Issue 2 (November 2015)

10. Active Smoking May Negatively Affect Response Rate, Progression‐Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. (5th December 2013)